Trial NCT02640534

View at ClinicalTrials.gov 
Org. Study IDs: SAKK 08/14 - IMPROVE

Last trial update was posted on 2023-06-27

MeSH Interventions

Metformin

MeSH Conditions

Prostatic Neoplasms

Other Conditions

Cancer of the Prostate Prostate Cancer

Stopping Reasons

The decision is based on the fact that with the current follow up of around 10 years, the relevant secondary endpoints can adequately be addressed according to protocol. The addition of follow up data will not significantly impact these results.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID